Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.

Literature DB >> 16304186

In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.

Manuel Cuenca-Estrella¹, Alicia Gomez-Lopez, Emilia Mellado, Guillermo Garcia-Effron, Araceli Monzon, Juan Luis Rodriguez-Tudela.

Abstract

The in vitro activities of ravuconazole against 575 clinical strains of Aspergillus spp. and 348 nondermatophyte non-Aspergillus spp. were analyzed. Ravuconazole was active against Aspergillus spp., other hyaline filamentous fungi, black molds, and some Mucorales. Species such as Scedosporium prolificans, Fusarium spp., and Scopulariopsis spp. were resistant to the triazole.

Entities: Chemical Species

Mesh：

Substances：

Year: 2005 PMID： 16304186 PMCID： PMC1315962 DOI： 10.1128/AAC.49.12.5136-5138.2005

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

27 in total

1. In vitro antifungal susceptibilities of Trichosporon species.

Authors: Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal: Antimicrob Agents Chemother Date: 2002-04 Impact factor: 5.191

2. Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi.

Authors: J L Rodriguez-Tudela; Erja Chryssanthou; Evangelia Petrikkou; Juan Mosquera; David W Denning; Manuel Cuenca-Estrella
Journal: J Clin Microbiol Date: 2003-11 Impact factor: 5.948

3. In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.

Authors: B Minassian; E Huczko; T Washo; D Bonner; J Fung-Tomc
Journal: Clin Microbiol Infect Date: 2003-12 Impact factor: 8.067

4. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.

Authors: Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzón; Juan L Rodriguez-Tudela
Journal: Antimicrob Agents Chemother Date: 2003-07 Impact factor: 5.191

5. Penetration of ravuconazole, a new triazole antifungal, into rat tissues.

Authors: Hiroshiege Mikamo; Xiang Hua Yin; Yoh Hayasaki; Yoshiko Shimamura; Keizo Uesugi; Nobuyuki Fukayama; Masaru Satoh; Teruhiko Tamaya
Journal: Chemotherapy Date: 2002-03 Impact factor: 2.544

6. Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study.

Authors: A Espinel-Ingroff; A Fothergill; J Peter; M G Rinaldi; T J Walsh
Journal: J Clin Microbiol Date: 2002-09 Impact factor: 5.948

7. Novel effect of voriconazole on conidiation of Aspergillus species.

Authors: Neeraja L Varanasi; Inthumathi Baskaran; George J Alangaden; Pranatharthi H Chandrasekar; Elias K Manavathu
Journal: Int J Antimicrob Agents Date: 2004-01 Impact factor: 5.283

8. In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization.

Authors: Carolina Serena; Montserrat Ortoneda; Javier Capilla; F Javier Pastor; Deanna A Sutton; Michael G Rinaldi; Josep Guarro
Journal: Antimicrob Agents Chemother Date: 2003-10 Impact factor: 5.191

9. In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model.

Authors: D Andes; K Marchillo; T Stamstad; R Conklin
Journal: Antimicrob Agents Chemother Date: 2003-04 Impact factor: 5.191

10. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.

Authors: D J Diekema; S A Messer; R J Hollis; R N Jones; M A Pfaller
Journal: J Clin Microbiol Date: 2003-08 Impact factor: 5.948

14 in total

1. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

Authors: Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Guillermo Garcia-Effron; Juan L Rodriguez-Tudela
Journal: Antimicrob Agents Chemother Date: 2006-06 Impact factor: 5.191

2. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.

Authors: Magdalena Skóra; Małgorzata Bulanda; Tomasz Jagielski
Journal: Antimicrob Agents Chemother Date: 2015-06-22 Impact factor: 5.191

Review 3. Pharmacokinetic/pharmacodynamic profile of posaconazole.

Authors: Yanjun Li; Ursula Theuretzbacher; Cornelius J Clancy; M Hong Nguyen; Hartmut Derendorf
Journal: Clin Pharmacokinet Date: 2010-06 Impact factor: 6.447

4. In Vitro Activities of Ravuconazole and Isavuconazole against Dematiaceous Fungi.

Authors: Hailin Zheng; Nana Song; Huan Mei; Jiacheng Dong; Dongmei Li; Xiaofang Li; Weida Liu
Journal: Antimicrob Agents Chemother Date: 2020-08-20 Impact factor: 5.191

Review 5. Melanized fungi in human disease.

Authors: Sanjay G Revankar; Deanna A Sutton
Journal: Clin Microbiol Rev Date: 2010-10 Impact factor: 26.132

Review 6. Infections caused by Scedosporium spp.

Authors: Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal: Clin Microbiol Rev Date: 2008-01 Impact factor: 26.132

7. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.

Authors: Manuel Cuenca-Estrella; Ana Alastruey-Izquierdo; Laura Alcazar-Fuoli; Leticia Bernal-Martinez; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Juan L Rodriguez-Tudela
Journal: Antimicrob Agents Chemother Date: 2008-01-14 Impact factor: 5.191